Real-time enrollment status for this heterozygous or homozygous familial hypercholesterolemia clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 5:58 AM UTC
| NCT Number | NCT05682378 |
| Recruiting Status | Recruiting |
| Condition | Heterozygous or Homozygous Familial Hypercholesterolemia |
| Phase | PHASE3 |
| Target Enrollment | 195 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | May 15, 2026 (May 15, 2026) |
As of July 14, 2026: Clinical trial NCT05682378 is currently recruiting participants. This phase3 study for heterozygous or homozygous familial hypercholesterolemia is actively seeking new participants at 5 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05682378 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05682378 was last updated May 15, 2026 (May 15, 2026). HelloStudys verifies this status automatically.